Filtros de búsqueda

Lista de obras de Stacie Dusetzina

1863. Antibiotic Prescribing Before and After an FDA Boxed Warning on Fluoroquinolones in 2016

Adherence and out-of-pocket costs among Medicare beneficiaries who are prescribed oral targeted therapies for advanced prostate cancer

artículo científico publicado en 2020

Advancing Legislation on Drug Pricing - Is There a Path Forward?

scientific article published on 01 November 2019

Aggressive End-of-Life Care for Metastatic Cancer Patients Younger Than Age 65 Years.

artículo científico publicado en 2017

Antiemetics: ASCO Guideline Update

artículo científico publicado en 2020

Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update

artículo científico publicado en 2017

Are Small Reimbursement Changes Enough to Change Cancer Care? Reimbursement Variation in Prostate Cancer Treatment.

artículo científico publicado en 2016

Assessing disruptions in adherence to antidepressant treatments after breast cancer diagnosis.

artículo científico publicado en 2017

Assessment of Expected Out-of-Pocket Spending for Rheumatoid Arthritis Biologics Among Patients Enrolled in Medicare Part D, 2010-2019

artículo científico publicado en 2020

Association of Electronic Prescribing of Controlled Substances With Opioid Prescribing Rates

artículo científico publicado en 2020

Association of Prescription Drug Price Rebates in Medicare Part D With Patient Out-of-Pocket and Federal Spending.

artículo científico publicado en 2017

Associations Between Medicare Part D and Out-of-Pocket Spending, HIV Viral Load, Adherence, and ADAP Use in Dual Eligibles With HIV.

artículo científico publicado en 2018

Balancing Value with Affordability: Cell Immunotherapy for Cancer Treatment in the U.S.

scientific article published on 09 May 2020

Broken Promises - How Medicare Part D Has Failed to Deliver Savings to Older Adults

artículo científico publicado en 2020

Buprenorphine Use and Spending for Opioid Use Disorder Treatment: Trends From 2003 to 2015.

artículo científico publicado en 2018

Changes in Opioid Prescribing Patterns Among Generalists and Oncologists for Medicare Part D Beneficiaries From 2013 to 2017

artículo científico publicado en 2020

Changes in antipsychotic use among patients with severe mental illness after a Food and Drug Administration advisory

artículo científico publicado en 2012

Characteristics of Medicare Payments to Dermatologists in 2013

artículo científico publicado en 2017

Characterizing and assessing antiemetic underuse in patients initiating highly emetogenic chemotherapy

scientific article published on 26 March 2019

Comparative Safety and Health Care Expenditures Among Patients With Chronic Myeloid Leukemia Initiating First-Line Imatinib, Dasatinib, or Nilotinib

artículo científico publicado en 2020

Comparative Toxicity and Effectiveness of Trastuzumab-Based Chemotherapy Regimens in Older Women With Early-Stage Breast Cancer.

artículo científico

Comparative effectiveness of mitoxantrone plus prednisone versus prednisone alone in metastatic castrate-resistant prostate cancer after docetaxel failure

artículo científico publicado en 2015

Confounding control in a nonexperimental study of STAR*D data: logistic regression balanced covariates better than boosted CART.

artículo científico publicado en 2013

Confronting State Medicaid Drug Spending Pressures

artículo científico publicado en 2020

Control Outcomes and Exposures for Improving Internal Validity of Nonrandomized Studies.

artículo científico publicado en 2015

Controlling for drug dose in systematic review and meta-analysis: a case study of the effect of antidepressant dose

scientific article published on 13 January 2009

Cost of contraceptive methods to privately insured women in the United States

artículo científico publicado en 2013

Cost sharing and adherence to tyrosine kinase inhibitors for patients with chronic myeloid leukemia

artículo científico publicado en 2013

Cost-Effective But Unaffordable: The CAR-T Conundrum

scientific article published on 17 December 2018

Cost-Effectiveness Analysis of Monthly Zoledronic Acid, Zoledronic Acid Every 3 Months, and Monthly Denosumab in Women With Breast Cancer and Skeletal Metastases: CALGB 70604 (Alliance).

artículo científico publicado en 2017

Cost-Effectiveness of First-Line Tyrosine Kinase Inhibitor Therapy Initiation Strategies for Chronic Myeloid Leukemia

artículo científico publicado en 2020

Cost-Effectiveness of Multigene Pharmacogenetic Testing in Patients With Acute Coronary Syndrome After Percutaneous Coronary Intervention

artículo científico publicado en 2019

Cost-effectiveness of Tyrosine Kinase Inhibitor Treatment Strategies for Chronic Myeloid Leukemia in Chronic Phase After Generic Entry of Imatinib in the United States

artículo científico publicado en 2016

Decreased Antihyperglycemic Drug Use Driven by High Out-of-Pocket Costs Despite Medicare Coverage Gap Closure

artículo científico publicado en 2020

Depression affects adherence measurement but not the effectiveness of an adherence intervention in heart failure patients

artículo científico publicado en 2009

Disclosing Prescription-Drug Prices in Advertisements - Legal and Public Health Issues

artículo científico publicado en 2018

Disparities in Use of Human Epidermal Growth Hormone Receptor 2-Targeted Therapy for Early-Stage Breast Cancer.

artículo científico publicado en 2016

Distressing adverse events after antidepressant switch in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) trial: influence of adverse events during initial treatment with citalopram on development of subsequent adverse events wit

artículo científico publicado en 2012

Does Receipt of Recommended Elements of Palliative Care Precede In-Hospital Death or Hospice Referral?

artículo científico publicado en 2019

Does the presence of accompanying symptom clusters differentiate the comparative effectiveness of second-line medication strategies for treating depression?

artículo científico publicado en 2011

Drug Pricing Trends for Orally Administered Anticancer Medications Reimbursed by Commercial Health Plans, 2000-2014

artículo científico publicado en 2016

Drug vs class-specific black box warnings: does one bad drug spoil the bunch?

artículo científico publicado en 2011

Early Impact Of The Affordable Care Act On Oral Contraceptive Cost Sharing, Discontinuation, And Nonadherence

artículo científico publicado en 2016

Early Impact of the Affordable Care Act on Uptake of Long-acting Reversible Contraceptive Methods.

artículo científico publicado en 2016

Early Post-Therapy Prescription Drug Usage among Childhood and Adolescent Cancer Survivors

artículo científico publicado en 2018

Early Posttherapy Hospitalizations Among Survivors of Childhood Leukemia and Lymphoma

artículo científico publicado en 2016

Early supportive medication use and end-of-life care among Medicare beneficiaries with advanced breast cancer

artículo científico publicado en 2016

Effect of Part D coverage restrictions for antidepressants, antipsychotics, and cholinesterase inhibitors on related nursing home resident outcomes

artículo científico publicado en 2014

Effects of FDA advisories on the pharmacologic treatment of ADHD, 2004-2008

artículo científico publicado en 2013

Electronic Health Record Phenotypes for Identifying Patients with Late-Stage Disease: a Method for Research and Clinical Application

artículo científico publicado en 2019

Elements of Palliative Care in the Last 6 Months of Life: Frequency, Predictors, and Timing

artículo científico publicado en 2019

Endocrine Therapy Initiation among Older Women with Ductal Carcinoma In Situ

artículo científico publicado en 2017

Evaluating Indeterminate Interferon-γ-Release Assay Results in Patients With Chronic Inflammatory Diseases Receiving Immunosuppressive Therapy

scientific article published on 01 August 2015

Evaluating Surveillance Patterns after Chemoradiation-Only Compared with Conventional Management for Older Patients with Rectal Cancer

artículo científico publicado en 2019

Evaluating the Strength of the Association Between Industry Payments and Prescribing Practices in Oncology

artículo científico publicado en 2019

Examining Parental Medication Adherence as a Predictor of Child Medication Adherence in Pediatric Anxiety Disorders

artículo científico publicado en 2018

Examining potential gaps in supportive medication use for US and foreign-born Hispanic women with breast cancer

artículo científico publicado en 2018

Examining racial variation in antiemetic use and post-chemotherapy health care utilization for nausea and vomiting among breast cancer patients

artículo científico publicado en 2016

Factors Associated With Tyrosine Kinase Inhibitor Initiation and Adherence Among Medicare Beneficiaries With Chronic Myeloid Leukemia.

artículo científico publicado en 2016

Financial Relationships With Industry Among National Comprehensive Cancer Network Guideline Authors.

artículo científico publicado en 2016

Financial Toxicity in Adults With Cancer: Adverse Outcomes and Noncompliance

article

For uninsured cancer patients, outpatient charges can be costly, putting treatments out of reach

artículo científico publicado en 2015

Generic Price Competition For Specialty Drugs: Too Little, Too Late?

scientific article published on 01 May 2018

Health care utilization and steroid-refractory toxicities from immune checkpoint inhibitors

artículo científico publicado en 2019

High-risk medication use by nursing home residents before and after hospitalization.

artículo científico publicado en 2014

How Do Payers Respond to Regulatory Actions? The Case of Bevacizumab

artículo científico publicado en 2015

How The ACA Reframed The Prescription Drug Market And Set The Stage For Current Reform Efforts

artículo científico publicado en 2020

Immortal time bias or sorafenib effect in elderly patients with HCC?

artículo científico publicado en 2017

Impact of FDA drug risk communications on health care utilization and health behaviors: a systematic review

artículo científico publicado en 2012

Impact of Medicare Part D on mental health treatment and outcomes for dual eligible beneficiaries with HIV

artículo científico publicado en 2018

Implications of Removing Rosiglitazone's Black Box Warning and Restricted Access Program on the Uptake of Thiazolidinediones and Dipeptidyl Peptidase-4 Inhibitors Among Patients with Type 2 Diabetes

artículo científico publicado en 2019

Incidence of mental health hospitalizations, treated self-harm, and emergency room visits following new anxiety disorder diagnoses in privately insured U.S. children

article

Incident Substance Use Disorder Following Anxiety Disorder in Privately Insured Youth

scientific article published on 17 July 2019

Initiation of generic imatinib may improve medication adherence for patients with chronic myeloid leukemia

artículo científico publicado en 2019

Insurance instability and use of emergency and office-based care after gaining coverage: An observational cohort study

scientific article published on 04 September 2020

Investigating differences in treatment effect estimates between propensity score matching and weighting: a demonstration using STAR*D trial data

artículo científico publicado en 2012

Investigating racial disparities in use of NK1 receptor antagonists to prevent chemotherapy-induced nausea and vomiting among women with breast cancer

artículo científico publicado en 2016

Investigation of Racial Disparities in Early Supportive Medication Use and End-of-Life Care Among Medicare Beneficiaries With Stage IV Breast Cancer

artículo científico publicado en 2016

Linking Data for Health Services Research: A Framework and Instructional Guide

artículo científico publicado en 2014

Long-term Survival After Chemoradiotherapy Without Surgery for Rectal Adenocarcinoma: A Word of Caution.

artículo científico publicado en 2017

Low Uptake of Human Papillomavirus Vaccine Among Postpartum Women, 2006-2012.

artículo científico publicado en 2016

Medicaid prescription drug utilization and expenditures following Part D.

artículo científico publicado en 2010

Medicare Part D Plans Rarely Cover Brand-Name Drugs When Generics Are Available

artículo científico publicado en 2020

Medicare Part D and Insulin Affordability - The Devil Is in the Details

scientific article published on 01 April 2020

Medicare Part D plan generosity and medication use among dual-eligible nursing home residents

artículo científico publicado en 2013

Medicare's Variation in Out-of-Pocket Costs for Prescriptions: The Irrational Examples of In-Hospital Observation and Home Infusion

artículo científico publicado en 2018

Mental health service use for adult patients with co-occurring depression and physical chronic health care needs, 2007-2010

artículo científico publicado en 2015

Mind the Gap: Why Closing the Doughnut Hole Is Insufficient for Increasing Medicare Beneficiary Access to Oral Chemotherapy

artículo científico publicado en 2015

Mohs Micrographic Surgery Use in the United States Based on Medicare Data-Reply

artículo científico publicado en 2017

More evidence on the limited impact of state oral oncology parity laws

artículo científico publicado en 2018

ONCOLOGISTS' BARRIERS AND FACILITATORS FOR ONCOTYPE DX USE: QUALITATIVE STUDY.

artículo científico publicado en 2016

Obstacles to affordable cancer treatments

artículo científico publicado en 2014

Opioid use disorder and overdose in older adults with breast, colorectal, or prostate cancer

artículo científico publicado en 2020

Opportunities to Improve Detection and Treatment of Depression Among Patients With Breast Cancer Treated in an Integrated Delivery System

scientific article published on 01 December 2018

Oral Oncology Parity Laws, Medication Use, and Out-of-Pocket Spending for Patients with Blood Cancers

artículo científico publicado en 2019

Out-of-Pocket Spending Not Associated with Oral Oncolytic Survival Benefit

artículo científico publicado en 2018

Out-of-Pocket Spending Under the Affordable Care Act for Patients With Cancer

artículo científico publicado en 2017

Out-of-Pocket and Health Care Spending Changes for Patients Using Orally Administered Anticancer Therapy After Adoption of State Parity Laws

artículo científico publicado en 2017

Patient and Plan Spending after State Specialty-Drug Out-of-Pocket Spending Caps

artículo científico publicado en 2020

Patient-Centered Communication for Discussing Oncotype DX Testing.

artículo científico publicado en 2016

Patient-Clinician Decision Making for Stable Angina: The Role of Health Literacy

scientific article published on 09 August 2019

Pharmaceutical Industry Payments and Oncologists' Selection of Targeted Cancer Therapies in Medicare Beneficiaries

artículo científico publicado en 2018

Possible Insufficiency of Generic Price Competition to Contain Prices for Orally Administered Anticancer Therapies.

artículo científico publicado en 2017

Post-discharge Health Services Use for Patients with Serious Mental Illness Treated at an Emergency Department Versus a Dedicated Community Mental Health Center

scientific article published on 07 December 2019

Predictors of Human Papillomavirus Vaccine Follow-Through Among Privately Insured US Patients

artículo científico publicado en 2018

Prescription Drug Coverage and Outcomes of Myeloma Therapy Among Medicare Beneficiaries

scientific article published on 16 August 2018

Prescription Drug Utilization and Reimbursement Increased Following State Medicaid Expansion in 2014.

artículo científico publicado en 2017

Prescription Drugs-List Price, Net Price, and the Rebate Caught in the Middle

scientific article published on 01 April 2019

Prescription refill records as a screening tool to identify antidepressant non-adherence.

artículo científico publicado en 2010

Prevalence of bipolar disorder diagnoses and psychotropic drug therapy among privately insured children and adolescents

artículo científico publicado en 2012

Price Increases of Protected-Class Drugs in Medicare Part D, Relative to Inflation, 2012-2017

artículo científico publicado en 2019

Promotional payments made to urologists by the pharmaceutical industry and prescribing patterns for targeted therapies

artículo científico publicado en 2020

Propensity score estimation to address calendar time-specific channeling in comparative effectiveness research of second generation antipsychotics

artículo científico publicado en 2013

Proposals to Redesign Medicare Part D - Easing the Burden of Rising Drug Prices

scientific article published on 04 September 2019

Psychotherapy Claims Surrounding Pharmacotherapy Initiation in Children and Adolescents with Anxiety Disorders

artículo científico publicado en 2018

Racial Variation in the Uptake of Oncotype DX Testing for Early-Stage Breast Cancer.

artículo científico publicado en 2015

Racial disparities in initiation of adjuvant endocrine therapy of early breast cancer

artículo científico publicado en 2014

Racial variation in adjuvant chemotherapy initiation among breast cancer patients receiving oncotype DX testing.

artículo científico publicado en 2015

Racial-ethnic differences in incident olanzapine use after an FDA advisory for patients with schizophrenia

artículo científico publicado en 2013

Real-Time Benefit Tools for Drug Prices

scientific article published on 25 October 2019

Receipt of guideline-concordant pharmacotherapy among children with new diagnoses of bipolar disorder

artículo científico publicado en 2011

Recommendations for Lowering Prescription Drug Spending in Public Programs

scientific article published on 12 November 2019

Reply to E. Ritchie et al

scientific article published on 13 February 2017

Revisiting the washout period in the incident user study design: why 6-12 months may not be sufficient

artículo científico publicado en 2015

Risk of adverse events in treatment-resistant depression: propensity-score-matched comparison of antidepressant augment and switch strategies.

artículo científico publicado en 2011

Sending The Wrong Price Signal: Why Do Some Brand-Name Drugs Cost Medicare Beneficiaries Less Than Generics?

scientific article published on 01 July 2019

Share Of Specialty Drugs In Commercial Plans Nearly Quadrupled, 2003-14.

artículo científico publicado en 2016

Sorafenib Effectiveness in Advanced Hepatocellular Carcinoma.

artículo científico publicado en 2016

Specialty Drug Pricing and Out-of-Pocket Spending on Orally Administered Anticancer Drugs in Medicare Part D, 2010 to 2019

scientific article published on 01 May 2019

Spending by Commercial Insurers on Chemotherapy Based on Site of Care, 2004-2014

artículo científico publicado en 2018

Subsidies for Oral Chemotherapy and Use of Immunomodulatory Drugs Among Medicare Beneficiaries With Myeloma

artículo científico publicado en 2017

Systemic therapy in men with metastatic castration-resistant prostate cancer:American Society of Clinical Oncology and Cancer Care Ontario clinical practice guideline

artículo científico publicado en 2014

The Association Between Long-Term Bisphosphonate Use and the Risk of Fracture Among Women Aged 50 or Older with Osteoporosis.

artículo científico publicado en 2016

The Association Between Medicare Low-income Subsidy and Anticancer Treatment Uptake in Advanced Lung Cancer

artículo científico publicado en 2019

The association between trajectories of endocrine therapy adherence and mortality among women with breast cancer.

artículo científico publicado en 2016

The effect of a celebrity health disclosure on demand for health care: trends in BRCA testing and subsequent health services use.

artículo científico publicado en 2017

The impact of emerging safety and effectiveness evidence on the use of physician-administered drugs: the case of bevacizumab for breast cancer

artículo científico publicado en 2013

The impact of out-of-pocket costs on the use of intrauterine contraception among women with employer-sponsored insurance.

artículo científico publicado en 2013

The project data sphere initiative: accelerating cancer research by sharing data

artículo científico publicado en 2015

Therapy Caps and Variation in Cost of Outpatient Occupational Therapy by Provider, Insurance Status, and Geographic Region.

artículo científico publicado en 2018

Treating Pediatric Anxiety: Initial Use of SSRIs and Other Antianxiety Prescription Medications.

artículo científico publicado en 2017

Treating depression after initial treatment failure: directly comparing switch and augmenting strategies in STAR*D.

artículo científico publicado en 2012

Treatment selection and medication adherence for stable angina: The role of area-based health literacy

artículo científico publicado en 2020

Treatment use and costs among privately insured youths with diagnoses of bipolar disorder

artículo científico publicado en 2012

Trends in Inpatient and Outpatient Hysterectomy and Oophorectomy Rates Among Commercially Insured Women in the United States, 2000-2014

artículo científico publicado en 2016

Trends in attention deficit hyperactivity disorder ambulatory diagnosis and medical treatment in the United States, 2000-2010.

artículo científico publicado en 2012

Trends in co-prescribing of antidepressants and tamoxifen among women with breast cancer, 2004-2010.

artículo científico publicado en 2012

Use and Costs for Tumor Gene Expression Profiling Panels in the Management of Breast Cancer From 2006 to 2012: Implications for Genomic Test Adoption Among Private Payers.

artículo científico publicado en 2015

Use of High-Cost Cancer Treatments in Academic and Nonacademic Practice

artículo científico publicado en 2019

Utilization of Long-Acting Reversible Contraceptives in the United States After vs Before the 2016 US Presidential Election

artículo científico publicado en 2019

Utilization of Standard and Target-Specific Oral Anticoagulants Among Adults in the United Kingdom With Incident Atrial Fibrillation.

artículo científico publicado en 2017

Variation in neoadjuvant chemotherapy utilization for epithelial ovarian cancer at high volume hospitals in the United States and associated survival.

artículo científico publicado en 2017

Weighing Costs and Benefits in the Economics of Cancer Care

scientific article published on 05 December 2019

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda